Abstract
Trazodone was labeled with 99mTc by indirect method. More than 97% radiochemical yield was reached under the following optimized conditions: 100 µg of Trazodone, pH 7, 10 mg of glucoheptonate, 35 µg of stannous chloride, 185 MBq of 99mTc eluate, 20 min, room temperature. The in vitro stability and also the retention of the complex in the brain tissue allow the use of this complex as a potential brain imaging agent.
Similar content being viewed by others
References
Saha, G.B., Fundamentals of Nuclear Pharmacy, New York: Springer, 2004, 5th ed., p. 79.
Handbook of Radiopharmaceuticals: Radiochemistry and Applications, Welch, M.J. and Carol, S., Eds., Wiley, 2003, p. 323.
Hyslop, D.K. and Allen, D.P., Drug Dev. Res., 1988, vol. 12, pp. 77–79.
Richelson, E. and Pfenning, M., Eur. J. Pharmacol., 1984, vol. 17, pp. 277–286.
Owens, M.J., Morgan, W.N., Plott, S.J., and Nemeroff, C.B., J. Pharmacol. Exp. Ther., 1997, vol. 283, pp. 1305–1322.
Ghanbari, R., El Mansari, M., and Blier, P., Eur. Neuropsychopharmacol., 2012, vol. 22, no. 7, pp. 518–526.
Ghanbari, R., and El Mansari, M., J. Pharmacol. Exp. Ther., 2010, vol. 335, pp. 197–206.
Mercolini, L., Colliva, C., Amore, M., et al., J. Pharm. Biomed. Anal., 2008, vol. 47, nos. 4–5, pp. 882–887.
Maes, M., Westenberg, H., and Vandoolaeghe, E., J. Clin. Psychopharmacol., 1997, vol. 17, no. 5, pp. 358–364.
Geerlings, P., de Proft, F., and Langenaeker, W., Chem. Rev., 2003, vol. 103, no. 5, pp. 1793–1873.
Carmo, V.A.S., Ferrari, C.S., Reis, E.C.O., et al., J. Nucl. Med. Commun., 2008, vol. 29, p. 33.
De Barros, A.L.B., Cardoso, V.N., Mota, L.G., et al., J. Bioorg. Med. Chem. Lett., 2009, vol. 19, p. 2497.
Lam, S. and Boselli, L., J. Biomed. Chromatogr., 1986, vol. 1, no. 4, pp. 177–179.
Liu, F.E.I., Youfeng, H.E., and Luo, Z., Tech. Rep. Ser., Vienna: IAEA, 2004, no. 426, pp. 37–52.
Politzer, P. and Murray, J.S., Theor. Chem. Acc., 2002, vol. 108, no. 3, pp. 134–142
Murray, J. and Politzer, P., WIREs Comput. Mol. Sci., 2011, no. 1, pp. 153–163.
Amin, A.M., El-Azony, K.M., and Ibrahim, I.T., J. Label. Compd. Radiopharm., 2009, vol. 52, no. 11, pp. 467–472.
Korde, A., Kameswaran, M., Satpati, D., et al., Appl. Radiat. Isot., 2015, vol. 96, pp. 57–62.
Al-Hokbany, N.S., Mhafouz, H., and Al-Jammaz, I.J., J. Biophys. Chem., 2011, vol. 2, no. 2, pp. 92–101.
Motaleb, M.A., Ibrahim, I.T., Ayoub, V.R., and Geneidi, A.S., J. Label. Compd. Radiopharm., 2016, vol. 59, pp. 147–152.
Ibrahim, I.T., Motaleb, M.A., and Attalah, K.M., J. Radioanal. Nucl. Chem., 2010, vol. 285, no. 3, pp. 431–436.
Baker, G.B., Coutts, R.T. and Greenshaw, A.J., J. Psych. Neurosci., 2000, vol. 25, no. 5, pp. 481–496.
Greenblatt, D.J., von Moltke, L.L., Harmatz, J.S., and Shader, R.I., J. Clin. Psychopharmacol., 1999, vol. 19, no. 1, pp. 23S–35S.
Neirinckx, R.D., Canning, L.R., Piper, I.M., et al., J. Nucl. Med., 1987, vol. 28, pp. 191–202.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
El-Sabagh, H.A., Talaat, H.M. & Abdel-Mottaleb, M.S.A. Preparation and Biodistribution of 99mTc-Trazodone as a Brain Imaging Probe. Radiochemistry 61, 93–98 (2019). https://doi.org/10.1134/S1066362219010144
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1066362219010144